I really don't want to be a doctor

Chapter 190 Hottest Fields of Research

"Mr. Zhu?"

Jing Xiaoran stretched out his hand in the air, and looked at Zhu Xianqing with a puzzled expression.

"Jing, Jing Xiaoran, that..."

Zhu Xianqing was stunned, he had talked with Jing Xiaoran on the phone before, and learned something about Jing Xiaoran from Hamer.

But he really didn't expect that Jing Xiaoran looked so ordinary.

Although it is said that people should not be judged by their appearance, more often than not, a person's professional status and living conditions can be judged by his appearance.

What is external can determine what is internal to a certain extent.

From the outside, Jing Xiaoran doesn't look like a scientific researcher at all.

"Is there something wrong?"

Jing Xiaoran stood up straight and asked again.

His outstretched palm was still hanging in mid-air.

Zhu Xianqing coughed, stretched out his palm and shook Jing Xiaoran lightly, and then said: "To tell you the truth, you are indeed different from what I expected."

"Different? What's different?"

Jing Xiaoran looked down at his attire.

This, isn't this in line with my temperament?

"Forget it, let's not discuss this issue, let's go to the laboratory first."

Zhu Xianqing avoided this topic.

This time he came here mainly to inspect the equipment conditions of the laboratory, and Jing Xiaoran, the helm of the future laboratory.

Originally, he was full of expectations for this trip, but now seeing Jing Xiaoran's state, his heart beats like a drum. Can Jing Xiaoran really manage a laboratory well?

He really has the ability to lead the work of a laboratory?
"OK then."

Jing Xiaoran saw Zhu Xianqing's abnormality, but didn't say much.

He took Zhu Xianqing's luggage and hailed a taxi by the side of the road.

"Mr. Zhu, the laboratory is near Optics Valley, about half an hour's drive away."

Zhu Xianqing nodded and followed Jing Xiaoran into the taxi.

Along the way, Jing Xiaoran started chatting with Zhu Xianqing.

Dr. Zhu Xianqing stayed in the R&D department of Pfizer after graduation. He has worked in Pfizer for nearly ten years, but he is the backbone of Pfizer.

From the fact that he independently led a research and development team in Pfizer, it can be seen that he has a high status within it.

Although not as powerful as Hammer, he still has a lot of say in the R&D department.

"Mr. Zhu, Tingshu, are you from Xijiang?"

"Well, at the most famous satellite launch base in China." Zhu Xianqing said.

"That's good. Xijiang is so close to Fancheng. If you stay in our laboratory in the future, it will be very convenient to go home."

Zhu Xianqing nodded with a light smile, but didn't say much, just quietly watching the passing scenery outside the window.

Now, Jing Xiaoran clearly sensed that Zhu Xianqing's state was not right.

During the phone call with him before, Jing Xiaoran could feel that he was very interested in the laboratory, and he did not reject the matter of staying in Fancheng.

But now, his attitude seems to have become a little cold and elusive.

But it depends on human effort, Jing Xiaoran has known Zhu Xianqing before, and is still very optimistic about his future.

After all, researchers who are willing to return to China from the Lighthouse Country are trustworthy after thinking about it.

"Mr. Zhu, I think your work at Pfizer has always been about tumor drugs." Jing Xiaoran asked suddenly, "What do you think of the current prospects of tumor treatment?"

The research and development of drugs for tumor treatment can definitely be regarded as a hot spot in the field of global medicine. Every year, a large amount of funds are injected into the market for cancer drug research and development.

As long as a drug is developed, even if it can only improve the life of tumor patients for dozens of days, the economic effect it brings is huge.

From the movie "I'm Not the God of Medicine", we can clearly know the status of anti-tumor in the medical circle.

"tumor treatment?"

Zhu Xianqing was taken aback when he heard the words, he didn't expect Jing Xiaoran to ask this question on his own initiative.

He originally planned to "investigate" Jing Xiaoran, communicate with him about scientific research in depth, and then decide whether to stay or not.

"Looking at the entire global field of anti-tumor drug research and development, targeted therapy is currently the most prominent." Zhu Xianqing thought for a while and said, "This field has the most research. In Pfizer, most tumor teams focus on this aspect. "

Tumor-targeted therapy is a treatment method aimed at the identified cancer-causing site at the cellular molecular level (the site can be a protein molecule inside a tumor cell or a gene fragment).

Corresponding therapeutic drugs can be designed. When the drugs enter the body, they will specifically select the carcinogenic sites to combine and act, so that the tumor cells can die specifically without affecting the normal tissue cells around the tumor. Therefore, molecular targeted therapy is also called "Biological Missile".

Different from traditional cytotoxic chemotherapy, tumor molecular targeted therapy has a specific anti-tumor effect, and the toxicity is significantly reduced, creating a new field of tumor chemotherapy.

When Jing Xiaoran heard Zhu Xianqing's answer, he smiled lightly and said, "Mr. Zhu, do you really think so?"

Indeed, molecular targeted therapy for tumors is considered popular in the local area, and many new drugs originate from the field of targeted therapy.

"So, classmate Jing, don't you think targeted tumor therapy is not the future development trend?"

Zhu Xianqing asked with a smile.

A gleam of light flashed in Jing Xiaoran's eyes, it seems that this drug researcher from Pfizer is not a fuel-efficient lamp!
Is he "examining" himself in a disguised form?
Jing Xiaoran remembered that Zhu Xianqing once asked him about immune checkpoint inhibitors, but now he started to play riddles for himself, and he didn't talk about tumor immunotherapy, but molecular targeted therapy.

But it is true, if there are no two brushes, ordinary people will not sit in the position of Pfizer executives.

Jing Xiaoran nodded and said with a smile: "Targeted tumor therapy is a hot research field in the world, and many academic experts are also from the field of targeted therapy. I agree with Mr. Zhu's point of view."

"Nothing." Jing Xiaoran paused when he said this, glanced at Zhu Xian, and continued, "I think tumor immunotherapy will be the mainstream in the medical circle in the future!"

"Targeted therapy is very good, but compared with tumor immunotherapy, for immune checkpoint inhibitors, targeted therapy still has to stand aside!"

Zhu Xianqing was slightly taken aback, he didn't expect Jing Xiaoran to speak so decisively, and his tone was so unquestionable.

At present, on a global scale, immune checkpoint inhibitors have not yet been developed.

Although immune checkpoint inhibitors are highly anticipated by many people, they cannot be proven effective now, and most people in the medical circle are holding a wait-and-see attitude.

According to the current market situation, targeted therapy has proven its efficacy, and as more and more targets are discovered, targeted tumor therapy will be a hot research field for a long time in the future.

Therefore, Zhu Xianqing did not deliberately not mention tumor immunotherapy, but he thinks this is the most accurate statement.

"Student Jing, where did you get your confidence?" Zhu Xianqing was a little puzzled, "Are you so sure that tumor immunotherapy will surpass targeted therapy in the future?"

(End of this chapter)